Home » National Institutes Of Health » NIH » Science and Research » FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals September 12, 2021 Medline-NIH Off National Institutes Of Health, NIH, Science and Research 000000000000Related MedlinePlus Pages: COVID-19 Vaccines, Immune System and Disorders Read Original Article: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals » Previous: 5 Things You Need to Know about the COVID-19 Vaccine for Adolescents 12 through 17 Next: Concrete commitments needed to aid Afghan people, declares UN relief chief About The Author Medline-NIH
